This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Erik Lars Malmerberg
Introduction
Erik Lars Malmerberg is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on amido heteroaromatic compounds. His research focuses on compounds that have potential applications in treating various diseases, including liver disease.
Latest Patents
Erik Lars Malmerberg holds 1 patent for his invention related to amido heteroaromatic compounds. The patent specification details the compounds of Formula (I) and their pharmaceutically acceptable salts. It also outlines the processes and intermediates used for their preparation, as well as the pharmaceutical compositions that contain these compounds.
Career Highlights
Erik is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address critical health issues. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Erik has collaborated with several esteemed colleagues, including Tord Bertil Inghardt and Jens Peter Brandt. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Erik Lars Malmerberg's contributions to pharmaceutical innovation exemplify the impact of dedicated research and collaboration in the field. His work continues to influence the development of new treatments for diseases, showcasing the importance of innovation in healthcare.